What is Asteres?
Asteres Inc. operates at the intersection of healthcare delivery and automated retail technology. The company specializes in the design and deployment of secure, self-service kiosks and locker systems that facilitate the rapid, convenient pickup of prescriptions and essential healthcare products. By streamlining the pharmacy workflow, Asteres addresses the growing demand for contactless, 24/7 access to medications, thereby reducing wait times and enhancing patient satisfaction in clinical and retail pharmacy settings. Its market position is defined by its ability to integrate complex security protocols with user-friendly interfaces, serving as a vital link in the modern patient care continuum.
How much funding has Asteres raised?
Asteres has raised a total of $4.9M across 3 funding rounds:
Series C
$4M
Debt
$350K
Debt
$577K
Series C (2007): $4M with participation from Forward Ventures, Pacific Venture Capital, and Sanderling Ventures
Debt (2020): $350K led by PPP
Debt (2021): $577K supported by PPP
Key Investors in Asteres
Forward Ventures
Forward Ventures is a prominent San Diego-based life-science venture capital firm with over $450 million under management, focusing on biopharmaceutical therapeutics and innovative medical solutions.
Pacific Venture Capital
Pacific Venture Capital LLC is a specialized investment firm operating within the venture capital and private equity sector, providing strategic support to emerging growth companies.
Sanderling Ventures
Sanderling Ventures is a pioneering investment firm founded in 1979 that specializes in building new biomedical companies through early-stage financing and active management.
What's next for Asteres?
With the recent infusion of capital, Asteres is well-positioned to accelerate its enterprise-level expansion. The strategic focus will likely center on deepening its footprint within major health systems and pharmacy chains, where the demand for automated, secure medication dispensing is at an all-time high. As the company moves beyond its initial growth phases, the emphasis will shift toward enhancing its software ecosystem and scaling its hardware deployment capabilities. By leveraging its established relationships with institutional investors, Asteres is poised to capitalize on the broader digital transformation of the pharmaceutical supply chain, ensuring that its automated solutions remain the industry standard for secure, patient-centric medication delivery.
See full Asteres company page
